Product Description
Product Name: Human Albumin 20% injection
Main component:
Human albumin
This product is made from the plasma of healthy individuals. It is purified by the low-temperature ethanol protein separation method and then subjected to virus inactivation at 60°C for 10 hours.
Excipients:
Sodium caprylate.
Physical Properties:
This product is a slightly viscous, clear liquid that is yellow, green or brown in color. It should not be cloudy.
Indications
- Shock caused by blood loss or burns.
- Increased intracranial pressure caused by brain edema and injury.
- Edema or ascites caused by liver cirrhosis and kidney disease.
- Prevention and treatment of hypoproteinemia.
- Neonatal hyperbilirubinemia.
- It is used for cardiopulmonary bypass surgery, as an adjunctive treatment for burns, as an adjunctive treatment for hemodialysis, and for adult respiratory distress syndrome.
Usage and Dosage
Usage: Generally, intravenous infusion or intravenous injection is adopted. To prevent dehydration of body tissues during large-scale injection, it can be appropriately diluted with 5% glucose injection or sodium chloride injection for intravenous infusion (it is advisable to use a blood transfusion set equipped with a filter). The infusion rate should not exceed 2 ml per minute. However, within the first 15 minutes, special attention should be paid to a slow speed, gradually increasing to the above rate.
Dosage: The dosage should be determined by the physician as appropriate. Generally, for shock caused by severe burns or blood loss, 5 to 10 grams of this product can be directly injected, and repeated every 4 to 6 hours. When treating chronic albumin deficiency conditions such as nephropathy and liver cirrhosis, 5 to 10 grams of this product can be injected daily until edema subsides and the serum albumin content returns to normal.
Adverse Reactions
Adverse reactions are generally not observed when using this product. Occasionally, symptoms such as chills, fever, facial flushing, rash, nausea and vomiting may occur. Rapid infusion may cause vascular overload leading to pulmonary edema. Allergic reactions are rare.